Document is current
Any future updates will be listed below
-
Authors
Sukhavasi, Katyayani https://orcid.org/0000-0001-5627-0163
Mocci, Giuseppe
Ma, Lijiang
Hodonsky, Chani J. https://orcid.org/0000-0001-8566-5877
Diez Benevante, Ernest https://orcid.org/0000-0002-4313-4290
Muhl, Lars https://orcid.org/0000-0003-0952-0507
Liu, Jianping https://orcid.org/0000-0002-7336-3895
Gustafsson, Sonja
Buyandelger, Byambajav
Koplev, Simon https://orcid.org/0000-0002-8586-5614
Lendahl, Urban
Vanlandewijck, Michael
Singha, Prosanta
Örd, Tiit
Beter, Mustafa https://orcid.org/0000-0002-9497-3414
Selvarajan, Ilakya
Laakkonen, Johanna P.
Väli, Marika
den Ruijter, Hester M.
Civelek, Mete https://orcid.org/0000-0002-8141-0284
Hao, Ke https://orcid.org/0000-0002-1815-9197
Ruusalepp, Arno
Betsholtz, Christer
Järve, Heli
Kovacic, Jason C.
Miller, Clint L. https://orcid.org/0000-0003-4276-3607
Romanoski, Casey
Kaikkonen, Minna U. https://orcid.org/0000-0001-6294-0979
Björkegren, Johan L. M. https://orcid.org/0000-0003-1945-7425
- License Information
-
More Information
Article History
Received: 23 February 2024
Accepted: 17 February 2025
First Online: 10 April 2025
Change Date: 12 September 2025
Change Type: Update
Change Details: In the version of the article initially published, Simon Kolplev was incorrectly listed with two affiliations. This has been corrected in the HTML and PDF versions of the article so that “Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK” is Simon Kolplev’s only affiliation.
Competing interests
: J.L.M.B. and A.R. are shareholders of Clinical Gene Networks AB (CGN) that has an invested interest in STARNET. C.L.M. has received funding from AstraZeneca for an unrelated project. All other authors declare no competing interests.
